|
Re: Coronavirus
Quote:
Originally Posted by Pierre
I think we all share that hope.
However, do you have any legitimate reason to think that may be the case?
The Kent, Indian, Brazilian, South African variants are all non-vaccine resistant.
We’ll feel better by not worrying about “what ifs” and focusing on “what ares”
|
That's not how risk management works...
---------- Post added at 20:38 ---------- Previous post was at 20:37 ----------
Quote:
Originally Posted by Pierre
He making a perfectly acceptable assumption based on available evidence. The vaccines currently work on all variants.
So much fear and trepidation, do you get out of bed in the morning or just lay there quivering under the covers all day?
|
You mean on this virus that's been around for 18 months, that people said "don't worry about it" at the beginning of last year, and that we are still learning about, including the issues with Long Covid?
https://finance.yahoo.com/news/covid...190403035.html
Quote:
|
Antibody drugs and COVID-19 vaccines are less effective against a coronavirus variant that was first detected in India, according to researchers. The variant, known as B.1.617.2, has mutations that make it more transmissible. It is now predominant in some parts of India and has spread to many other countries. A multicenter team of scientists in France studied a B.1.617.2 variant isolated from a traveler returning from India. Compared to the B.1.1.7 variant first identified in Britain, the India variant was more resistant to antibody drugs, although three currently approved drugs still remained effective against it, they found. Antibodies in blood from unvaccinated COVID-19 survivors and from people who received both doses of the Pfizer/BioNTech vaccine were 3-fold to 6-fold less potent against the India variant than against the UK variant and a variant first identified in South Africa, according to a report posted on Thursday on the website bioRxiv ahead of peer review. The two-dose AstraZeneca vaccine, which does not protect against the South Africa variant, is likely to be ineffective against the India variant as well. Antibodies from people who had received their first dose "barely inhibited" this India variant, said study co-author Olivier Schwartz of Institut Pasteur. The study, Schwartz added, shows that the rapid spread of the India variant is associated with its ability to "escape" the effect of neutralizing antibodies. (https://bit.ly/3fQLeJ0)
|
__________________
Thank you for calling the Abyss.
If you have called to scream, please press 1 to be transferred to the Void, or press 2 to begin your stare.
If my post is in bold and this colour, it's a Moderator Request.
Last edited by Hugh; 30-05-2021 at 20:49.
|